Top of the Street: Sika, Haleon, Anglo American, VAT Group
A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
** Stifel raises Swiss chemicals maker Sika SIKA.S to "buy" from "hold" after it increased its PT to CHF 270, which implies an upside of 11%, following the recent share price drop
** Goldman Sachs cuts consumer healthcare company Haleon HLN.L to "neutral" from "buy", as it sees limited catalysts to drive near term price performance, with Pfizer's 22.6% remaining holding an overhang in the short term
** Panmure Liberum cuts British miner Anglo American AAL.L to "sell" from "hold" as it says the industry is now loss making, prompting an early start to 2024's destock, inflating the industry's ore and scrap surpluses
** RBC raises Swiss industrial valves maker Vat Group VACN.S to "sector perform" from "underperform" , saying it remains overall confident on the World Federation Exchanges(WFE) market outlook and the company's role within as the radical market correction made it revisit the investment case
** Jefferies cuts Sweden's Orphan Biovitrum SOBIV.ST to "hold" from "buy", citing increasing competition pressure for the Swedish drug maker
** Deutsche Bank raises British asset manager Intermediate Capital Group ICGIN.L to "buy" from "hold", citing a 29% upside from the current share price to its unchanged PT and a FY 2025 dividend yield of about 4%
INITIATIONS AND REINSTATEMENTS
** Morgan Stanley resumes coverage of Spanish utility Naturgy NTGY.MC with "equal-weight" rating, citing improving fundamentals, but it flags low liquidity
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
($1 = 0.7868 pounds)
($1 = 0.8542 Swiss francs)
($1 = 10.5790 Swedish crowns)
Reporting by Jakub Olesiuk and Paolo Laudani
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
